Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Effect of nutritional support on postoperative period in diabetic patients with protein and energy deficiency after limb amputation].

Created on 14 Nov 2026

Authors

A P Vlasov, T L Pilat, A A Abramov, Yu G Kuznetsova

Published in

Khirurgiia. Issue 11. Pages 85-94.

Abstract

To analyze efficacy and safety of postoperative nutritional support using LEOVIT PHARMA therapeutic enteral nutrition in patients with diabetes mellitus after limb amputation.
A prospective randomized study included 119 patients (80 in the study group and 39 in the control group) with type 2 diabetes mellitus (DM2). All patients signed an informed consent to participate in clinical study. Inclusion criteria: patient consent to participate; age over 18 years; primary diagnosis of DM2, diabetic angiopathy, and lower-limb gangrene; surgical intervention involving amputation of thigh, lower leg or toes; mild, moderate, or severe protein-energy malnutrition; ECOG score > 2-3; PG-SGA score ≥ 9. Exclusion criteria: patient refusal to participate at any stage; allergic or adverse reactions at any stage; severe mental illness. Patients were assigned to groups using a cluster method (ratio 2:1). Regarding nutritional support regimen, patients in the study group were prescribed LEOVIT PHARMA enteral nutrition according to the manufacturer's protocol. For the first 3 days prior to surgery, patients received a restorative protein shake (one single-serving packet, 4 times daily). Postoperatively, they received a detoxifying protein shake for subsequent 6 days (4 times daily). Patients received LEOVIT PHARMA protein shake for a total of 9 days. Patients in the second group received standard enteral nutrition. Preoperative nutritional management relied primarily on standard low-calorie diet, while postoperative regimen consisted of a gentle (bland) diet.
A new oral nutritional supplement (sipping formula) facilitated reparative processes at the surgical site. Microscopic analysis of wound exudate revealed a shortened alteration phase of healing process and rapid onset of reparative phase. Specifically, regenerative-degenerative index in the study group in early postoperative period was 16.3-21.2% higher than in the control group (p<0.05). Studies noted a relatively rapid transformation of polyblasts into connective tissue cells. Sipping therapy using specialized LEOVIT PHARMA enteral formulas was associated with a 17.6% reduction in total number of complications (χ²=2.78, p=0.041).
This prospective randomized study demonstrates that LEOVIT PHARMA enteral nutrition product for patients with type 2 diabetes mellitus undergoing amputation is a highly effective and safe therapeutic component.

PMID:
43024528
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement